UnitedHealth Group director Baker sells $9,613 in stock

Director Charles D. Baker of UnitedHealth Group (NYSE:UNH), a $315 billion healthcare giant with a "GREAT" financial health rating according to InvestingPro, sold 27 shares of common stock on September 11, 2025, at a price of $356.05, for a total value of $9,613. The stock, trading at a P/E of 15.1, has shown significant momentum with a 10% gain over the past week.

Following the transaction, Baker indirectly holds zero shares through a trust. Baker also directly holds 1,248 shares of UnitedHealth Group, a company that has maintained dividend payments for 33 consecutive years. InvestingPro analysis reveals 12 additional key insights about UNH’s valuation and growth prospects, available in the comprehensive Pro Research Report, which transforms complex Wall Street data into actionable intelligence.

In other recent news, UnitedHealth Group’s CEO, Stephen Hemsley, met with Trump’s chief of staff, Susie Wiles, to discuss the Medicare health insurance program and other related issues. UBS has raised its price target for UnitedHealth Group to $378, maintaining a Buy rating, following the company’s reaffirmation of its 2025 outlook and consistent Stars ratings for 2027. Bernstein SocGen Group has reiterated its Outperform rating with a price target of $379, highlighting UnitedHealth’s stability ahead of its third-quarter earnings and noting that 78% of its Medicare Advantage members will be in 4+ star plans by 2026. Morgan Stanley also reiterated its Overweight rating with a $325 price target, expressing optimism about UnitedHealth’s progress in Medicare Advantage and Optum Health profit improvements. These developments reflect a positive sentiment among analysts concerning UnitedHealth’s strategic initiatives and future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.